Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Oral pre-exposure prophylaxis (PrEP) receipt and persistence among opioid-dependent people who inject drugs initiating PrEP for HIV prevention

Journal of Substance Use and Addiction Treatment(2025)10.1016/j.josat.2025.209693Source: DataRank Database

Oral pre-exposure prophylaxis (PrEP) receipt and persistence among opioid-dependent people who inject drugs initiating PrEP for HIV prevention is a research paper published in Journal of Substance Use and Addiction Treatment (2025). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 1.38)OA: greenTopics (38)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Michael Copenhaver,Ran Xu ORCID,Frederick L. Altice ORCID,Jeffrey A. Wickersham ORCID,Kamal Gautam ORCID

Live enrichment

PubMed:40222706 PMC:PMC12477707 OpenAlex:https://openalex.org/W4409359654

NIDA NIH HHS

Grant: R21 DA051934

NIDA NIH HHS

Grant: K01 DA051346

Gilead Sciences Inc

NIH

FWCI

1.38

Citation Percentile

0.8%

Citation Trend

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC12477707/

publisherhttps://api.elsevier.com/content/article/PII:S2949875925000724?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2949875925000724?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.josat.2025.209693

Fields of Study

HIV, Drug Use, Sexual RiskHIV/AIDS Research and InterventionsOpioid Use Disorder TreatmentHumansMalePre-Exposure ProphylaxisFemaleHIV InfectionsAdultSubstance Abuse, IntravenousOpioid-Related DisordersMiddle AgedAdministration, Oral

MeSH Terms

Administration, OralAdultFemaleHumansMaleMiddle AgedOpioid-Related DisordersHIV InfectionsSubstance Abuse, IntravenousPre-Exposure Prophylaxis

Keywords

Pre-exposure prophylaxisMedicineReceiptHuman immunodeficiency virus (HIV)Opioid epidemicOpioidPharmacologyFamily medicineInternal medicineMen who have sex with menSyphilisHIVPeople Who Inject DrugsOpioid Use DisorderSyringe Services Program

Sustainable Development Goals

SDG 0: Good health and well-being

Oral pre-exposure prophylaxis (PrEP) receipt and persistence among opioid-dependent people who inject drugs initiating PrEP for HIV prevention

FAIR Checklist

Authors (8)

Funding (4 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)